Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.

Metformin Inhibits ROS Production by Human M2 Macrophages via the Activation of AMPK

Open access
Nassif, Rana M., Chalhoub, Elias, Chedid, Pia, Hurtado-Nedelec, Margarita, Raya, Elia, Dang, Pham My-Chan, Marie, Jean-Claude, El-Benna, Jamel · 2022 · Biomedicines

Abstract

Metformin (1,1-dimethylbiguanide hydrochloride) is the most commonly used drug to treat type II diabetic patients. It is believed that this drug has several other beneficial effects, such as anti-inflammatory and anticancer effects. Here, we wanted to evaluate the effect of metformin on the production of reactive oxygen species (ROS) by human macrophages. Macrophages are generated in vivo from circulating monocytes depending on the local tissue environment. In vitro proinflammatory macrophages (M1) and anti-inflammatory macrophages (M2) can be generated by culturing monocytes in the presence of different cytokines, such as GM-CSF or M-CSF, respectively. We show that metformin selectively inhibited human monocyte differentiation into proinflammatory macrophages (M1) without inhibiting their differentiation into anti-inflammatory macrophages (M2). Moreover, we demonstrate that, in response to LPS, M2 macrophages produced ROS, which could be very harmful for nearby tissues, and metformin inhibited this process. Interestingly, metformin with LPS induced activation of the adenosine-monophosphate-activated protein kinase (AMPK) and pharmacological activation of AMPK by AICAR, a known AMPK activator, decreased ROS production, whereas the deletion of AMPK in mice dramatically enhanced ROS production in different types of immune cells. These results suggest that metformin exhibits anti-inflammatory effects by inhibiting the differentiation of human monocytes into M1 macrophages and by limiting ROS production by macrophages via the activation of AMPK.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biomedicines10020319

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Effect of metformin on human isolated monocytes’ polarization into M1 and M2 macrophages. Human monocytes were isolated from blood of healthy donors and incubated in the absence or presence of metformin (2 mM) and GM-CSF (50 ng/mL) and LPS (100 ng/mL) for 7 days and analyzed by flow cytometry using fluorescent anti-CD14, anti-CD16, and anti-CD80 antibodies (A). Human monocytes were isolated from blood of healthy donors and incubated in the absence or presence of metformin (2 mM) and M-CSF (50 ng/mL) and IL-4 (20 ng/mL) for 7 days and analyzed by flow cytometry using fluorescent anti-CD14, anti-CD16, and anti-CD163 and anti-CD200R antibodies (B). Cell sorting and profiling was completed using a FACS Canto II cytometer and DIVA software for analysis. Data are mean of fluorescence (n = 3). * p value < 0.05.
Figure 1 Effect of metformin on human isolated monocytes’ polarization into M1 and M2 macrophages. Human monocytes were isolated from blood of healthy donors and incubated in the absence or presence of metformin (2 mM) and GM-CSF (50 ng/mL) and LPS (100 ng/mL) for 7 days and analyzed by flow cytometry using fluorescent anti-CD14, anti-CD16, and anti-CD80 antibodies (A). Human monocytes were isolated from blood of healthy donors and incubated in the absence or presence of metformin (2 mM) and M-CSF (50 ng/mL) and IL-4 (20 ng/mL) for 7 days and analyzed by flow cytometry using fluorescent anti-CD14, anti-CD16, and anti-CD163 and anti-CD200R antibodies (B). Cell sorting and profiling was completed using a FACS Canto II cytometer and DIVA software for analysis. Data are mean of fluorescence (n = 3). * p value < 0.05.CC BY · PubMed Central
Figure 2 Effect of metformin on ROS production in M2 polarized macrophages. M2 macrophages were incubated in the absence or presence of metformin (1 and 2 mM), then stimulated by LPS (4 µg/mL) for 1 (A) and 3 h (B). The relative intracellular ROS production was determined by recording the reduction in NBT at 570 nm. Data are mean of O.D. ± SD (n = 3). * p value < 0.05.
Figure 2 Effect of metformin on ROS production in M2 polarized macrophages. M2 macrophages were incubated in the absence or presence of metformin (1 and 2 mM), then stimulated by LPS (4 µg/mL) for 1 (A) and 3 h (B). The relative intracellular ROS production was determined by recording the reduction in NBT at 570 nm. Data are mean of O.D. ± SD (n = 3). * p value < 0.05.CC BY · PubMed Central
Figure 3 Evaluation of the cytotoxic effects of metformin on monocytes and M2 polarized macrophages. Human monocytes (A–C) and M2 macrophages (D) were incubated in the absence or the presence of metformin (0.5, 1, and 2 mM) for different indicated time periods. Cytotoxicity was analyzed after the addition of cytoX reagent and measurement of absorbance at 450 nm. Data are mean of absorbance ± SD (n = 3).
Figure 3 Evaluation of the cytotoxic effects of metformin on monocytes and M2 polarized macrophages. Human monocytes (A–C) and M2 macrophages (D) were incubated in the absence or the presence of metformin (0.5, 1, and 2 mM) for different indicated time periods. Cytotoxicity was analyzed after the addition of cytoX reagent and measurement of absorbance at 450 nm. Data are mean of absorbance ± SD (n = 3).CC BY · PubMed Central
Figure 4 Effect of metformin on the expression of the NADPH oxidase components. M2 macrophages were incubated in the absence or the presence of 2 mM metformin then stimulated by LPS (4 µg/mL) for 1 and 3 h. The expression of gp91phox, p22phox, p47phox, and p67phox was evaluated compared to actin by SDS-PAGE and Western blot using specific antibodies (A). The gp91phox (B,C), p67phox (D,E), p47phox (F,G), p22phox (H,I) and actin bands from three experiments were quantified and expressed as mean ± SD.
Figure 4 Effect of metformin on the expression of the NADPH oxidase components. M2 macrophages were incubated in the absence or the presence of 2 mM metformin then stimulated by LPS (4 µg/mL) for 1 and 3 h. The expression of gp91phox, p22phox, p47phox, and p67phox was evaluated compared to actin by SDS-PAGE and Western blot using specific antibodies (A). The gp91phox (B,C), p67phox (D,E), p47phox (F,G), p22phox (H,I) and actin bands from three experiments were quantified and expressed as mean ± SD.CC BY · PubMed Central
Figure 5 Effect of metformin on the phosphorylation of Ser345 of p47phox and its upstream MAP kinases, p38MAPK, and ERK1/2 in M2 macrophages. M2 macrophages were incubated in the absence or the presence of 2 mM metformin, then stimulated by LPS (4 µg/mL) for 1 and 3 h. The phosphorylation of Ser345-p47phox, p38MAPK, and ERK1/2 was evaluated compared to actin by SDS-PAGE and Western blot using specific antibodies (A). The pSer345-p47phox (B,C), p38MAPK (D,E), and ERK1/2 (F,G) and actin bands from three experiments were quantified and expressed as mean ± SD.
Figure 5 Effect of metformin on the phosphorylation of Ser345 of p47phox and its upstream MAP kinases, p38MAPK, and ERK1/2 in M2 macrophages. M2 macrophages were incubated in the absence or the presence of 2 mM metformin, then stimulated by LPS (4 µg/mL) for 1 and 3 h. The phosphorylation of Ser345-p47phox, p38MAPK, and ERK1/2 was evaluated compared to actin by SDS-PAGE and Western blot using specific antibodies (A). The pSer345-p47phox (B,C), p38MAPK (D,E), and ERK1/2 (F,G) and actin bands from three experiments were quantified and expressed as mean ± SD.CC BY · PubMed Central
Figure 6 Effect of metformin on the phosphorylation of AMPK in M2 macrophages. M2 macrophages were incubated in the absence or presence of metformin (2 mM), then stimulated with LPS (4 µg/mL) for 1 (A) and 3 h (B). The phosphorylation of AMPK and the presence of actin were evaluated by SDS-PAGE and Western blot using specific antibodies. The corresponding bands for 1 hour (C) and 3 hours (D) from three experiments were quantified and expressed as mean ± SD (n = 3, * p < 0.05).
Figure 6 Effect of metformin on the phosphorylation of AMPK in M2 macrophages. M2 macrophages were incubated in the absence or presence of metformin (2 mM), then stimulated with LPS (4 µg/mL) for 1 (A) and 3 h (B). The phosphorylation of AMPK and the presence of actin were evaluated by SDS-PAGE and Western blot using specific antibodies. The corresponding bands for 1 hour (C) and 3 hours (D) from three experiments were quantified and expressed as mean ± SD (n = 3, * p < 0.05).CC BY · PubMed Central
Figure 7 Effect of AMPK activation in human isolated monocytes and AMPK depletion in murine whole blood and bone marrow cells on ROS production. Human monocytes were incubated in the absence or the presence of AICAR (1 mM), stimulated by fMLF (100 nM), and ROS production was measured by luminol-amplified chemiluminescence (A). ROS production of whole blood cells (B) and bone marrow cells (C) isolated from of wild-type mice and AMPKα1-/- mice increased in the presence of fMLF (100 nM). A stronger response to fMLF was observed with AMPKα1-/- versus wild-type cells. The induced luminol-amplified chemiluminescence was measured using the luminometer for 15 min. Data are mean of chemiluminescence (n = 3). * p value < 0.05 and ** p value < 0.01.
Figure 7 Effect of AMPK activation in human isolated monocytes and AMPK depletion in murine whole blood and bone marrow cells on ROS production. Human monocytes were incubated in the absence or the presence of AICAR (1 mM), stimulated by fMLF (100 nM), and ROS production was measured by luminol-amplified chemiluminescence (A). ROS production of whole blood cells (B) and bone marrow cells (C) isolated from of wild-type mice and AMPKα1-/- mice increased in the presence of fMLF (100 nM). A stronger response to fMLF was observed with AMPKα1-/- versus wild-type cells. The induced luminol-amplified chemiluminescence was measured using the luminometer for 15 min. Data are mean of chemiluminescence (n = 3). * p value < 0.05 and ** p value < 0.01.CC BY · PubMed Central
Figure 8 Schematic representation of metformin’s action on macrophage polarization, showing its anti-inflammatory and antioxidant effects on macrophages. Metformin inhibits the polarization of M1 macrophages while favoring M2 macrophages. In addition to this effect, metformin dampens ROS production by these cells. Metformin may exert its anti-inflammatory and antioxidant effects through the reduction in NOX2-induced ROS production in an AMPK-dependent manner.
Figure 8 Schematic representation of metformin’s action on macrophage polarization, showing its anti-inflammatory and antioxidant effects on macrophages. Metformin inhibits the polarization of M1 macrophages while favoring M2 macrophages. In addition to this effect, metformin dampens ROS production by these cells. Metformin may exert its anti-inflammatory and antioxidant effects through the reduction in NOX2-induced ROS production in an AMPK-dependent manner.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Research works printed but not linked: 1

  1. Katzung, B.G. (2017). Pancreatic Hormones & Antidiabetic Drugs. Basic & Clinical Pharmacology, McGraw-Hill Education.

Cited by

See all 68

Metadata

Authors
Nassif, R. M., Chalhoub, E., Chedid, P., Hurtado-Nedelec, M., Raya, E., Dang, P. M.-C., Marie, J.-C., & El-Benna, J.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • University of Balamand (LB)
  • Centre de Recherche sur l’Inflammation (CRI), Laboratoire d’Excellence Inflamex, Faculté de Médecine Xavier Bichat, Université de Paris, INSERM-U1149, CNRS-ERL8252, 75018 Paris, France
Venue
Biomedicines
Publisher
MDPI AG
Published
2022-01-29
Volume
10
Issue
2
Pages
319
ISSN
2227-9059 (ISSN-L)
OpenAlex
W4210604230
Cited by
63
References
60
Citations by year
2026: 15 · 2025: 16 · 2024: 22 · 2023: 7 · 2022: 3
FWCI
3.92
Type
journal article
Language
en
Open access
Locations
  • Biomedicines (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • HAL (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Agence Nationale de la Recherche (ANR-10-LABX-0017)
  • Institut National de la Santé et de la Recherche Médicale
  • Agence Universitaire de la Francophonie
  • Centre National de la Recherche Scientifique
  • Université de Paris
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
metformin, reactive oxygen species, M2 macrophages, AMPK, monocyte differentiation, M1 macrophages, anti-inflammatory activity, lipopolysaccharide, AICAR, type 2 diabetes, biguanides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin Inhibits ROS Production by Human M2 Macrophages via the Activation of AMPK. https://app.cochat.ai/papers/10.3390/biomedicines10020319
The paper
Nassif, R. M., Chalhoub, E., Chedid, P., Hurtado-Nedelec, M., Raya, E., Dang, P. M.-C., Marie, J.-C., & El-Benna, J. (2022). Metformin Inhibits ROS Production by Human M2 Macrophages via the Activation of AMPK. Biomedicines. https://doi.org/10.3390/biomedicines10020319

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.